Double cancer of gall bladder and bile duct not associated with anomalous junction of the pancreaticobiliary duct system

Japanese Journal of Clinical Oncology

Volumn 36, Issue 10, 2006, Pages 638-642

  Hori, Hiiroshige ^a   Ajiki, Tetsuo ^a   Fujita, Tsunenori ^a   Okazaki, Taro ^a   Suzuki, Yasuyuki ^a   Kuroda, Yoshikazu ^a   Fujimori, Takahiro ^b  

^a KOBE UNIVERSITY   (Japan)

^b DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Bile duct; Double cancer; Gall bladder; K ras; p53

Indexed keywords

CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; K RAS PROTEIN; PROTEIN P53;

ADULT; AGED; ANATOMY; ANTIGEN DETECTION; ARTICLE; BILE DUCT; BILE DUCT CANCER; CANCER SURGERY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GALLBLADDER CANCER; GENE MUTATION; GENETIC ANALYSIS; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; PANCREAS DUCT;

AGED; BILE DUCT NEOPLASMS; BILE DUCTS; BILIARY TRACT; CA-19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; FEMALE; GALLBLADDER NEOPLASMS; GENES, RAS; HUMANS; MALE; MIDDLE AGED; MUTATION; NEOPLASMS, MULTIPLE PRIMARY; PANCREATIC DUCTS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33750689531     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyl077     Document Type: Article

References (29)

1. Todani T, Tabuchi K, Watanabe Y, Kobayashi T. Carcinoma arising in the wall of congenital bile duct cysts. Cancer 1979;44:1134-41.
2. Ikoma A, Nakamura N, Miyazaki T, Maeda M. Double cancer of the gallbladder and common bile duct associated with anomalous junction of pancreaticobiliary ductal system. Surgery 1992;111:595-600.
3. Noguchi M, Maezawa N, Nakanishi Y, Matsuno Y, Shimosato Y, Hirohashi S. Application of the p53 gene mutation pattern for differential diagnosis of primary versus metastatic lung carcinomas. Diagn Mol Pathol 1993;2:29-35.
4. Sozzi G, Miozzo M, Pastorino U, Pilotti S, Donghi R, Giarola M, et al. Genetic evidence for an independent origin of multiple preneoplastic and neoplastic lung lesions. Cancer Res 1995;55:135-40.
5. Oda T, Tsuda H, Scarpa A, Sakamoto M, Hirohashi S. Mutation pattern of the p53 gene as a diagnostic marker for multiple hepatocellular carcinoma. Cancer Res 1992;52:3674-8.
6. Lunec J, Challen C, Wright C, Mellon K, Neal DE. c-erbB-2 amplification and identical p53 mutations in concomitant transitional carcinomas of renal pelvis and urinary bladder. Lancet 1992;339:439-40.
7. Habuchi T, Takahashi R, Yamada H, Kakehi Y, Sugiyama T, Yoshida O. Metachronous multifocal development of urothelial cancers by intraluminal seeding. Lancet 1993;342:1087-8.
8. Nees M, Homann N, Discher H, Andl T, Enders C, Herold-Mende C, et al. Expression of mutated p53 occurs in tumor-distant epithelia of head and neck cancer patients: A possible molecular basis for the development of multiple tumors. Cancer Res 1993;53:4189-96.
9. Wee A, Teh M, Raju GC. Clinical importance of p53 protein in gall bladder carcinoma and its precursor lesions. J Clin Pathol 1994;47:453-6.
10. Watanabe M, Asaka M, Tanaka J, Kurosawa M, Kasai M, Miyazaki T. Point mutation of K-ras gene codon 12 in biliary tract tumors. Gastroenterology 1994;107:1147-53.
11. Albores-Saavedra J, Nadji M, Morales AR, Henson DE. Carcinoembryonic antigen in normal, preneoplastic and neoplastic gallbladder epithelium. Cancer 1983;52:1069-72.
12. Davis RI, Sloan JM, Hood JM, Maxwell P. Carcinoma of the extrahepatic biliary tract: A clinicopathological and immunohistochemical study. Histopathology 1988;12:623-31.
13. Kimura W, Miyata R, Takahashi T, Yamashiro M. Simultaneous development of gall bladder and bile duct carcinomas with atypical epithelium intervention: A case report. Jpn J Clin Oncol 1989;19:287-93.
14. The Japanese Study Group on Pancreaticobiliary Maljunction; the Committee of JSPBM for diagnostic criteria. Diagnostic criteria of pancreaticobiliary maljunction. J Hepatobiliary Pancreat Surg 1994;1:219-21.
15. Japanese Society of Biliary Surgery. General Rules for Surgical and Pathological Studies on Cancer of the Biliary Tract. 5th edn. Tokyo: Kanehara 2003.
16. Ajiki T, Onoyama H, Asaka K, Fujimori T, Maeda S, Yamamoto M, et al. p53 protein expression and prognosis in gallbladder carcinoma and premalignant lesions. Hepato-Gastroenterol 1996;43:521-6.
17. Yukawa M, Fujimori T, Maeda S, Tabuchi M, Nagasako K. Comparative clinicopathological and immunohistochemical study of ras and p53 in flat and polypoid type colorectal tumours. Gut 1994;35:1258-61.
18. Hamada Y, Yamamura M, Hioki K, Yamamoto M, Nagura H, Watanabe K. Immunohistochemical study of carcinoembryonic antigen in patients with colorectal cancer: Correlation with plasma carcinoembryonic antigen levels. Cancer 1985;55:136-41.
19. Sasaki R. Immunohistochemical study of cancer-associated carbohydrate antigens in carcinoma of the biliary tract. Jpn J Gastroenterol 1989; 90:1976-88.
20. Ajiki T, Fujimori T, Onoyama H, Yamamoto M, Kitazawa S, Maeda M, et al. K-ras gene mutation in gall bladder carcinomas and dysplasia. Gut 1996;38:426-9.
21. Warren S, Gates O. Multiple primary malignant tumors: A survey of the literature and a statistical study. Am J Cancer 1932;16:1358-414.
22. Moertel CG. Multiple primary malignant neoplasms: Histological perspectives. Cancer 1977;40:1786-92.
23. Fujii T, Kaneko T, Sugimoto H, Okochi O, Inoue S, Takeda S, et al. Metachronous double cancer of the gallbladder and common bile duct. J Hepatobiliary Pancreat Surg 2004;11:280-5.
24. Kobayashi S, Asano T, Yamasaki M, Kenmochi T, Nakagohri T, Ochiai T. Risk of bile duct carcinogenesis of extrahepatic bile ducts in pancreaticobiliary maljunction. Surgery 1999;126:939-44.
25. Fahim RB, McDonald JR, Richards JC, Ferris DO. Carcinoma of the gallbladder: A study of its modes of spread. Ann Surg 1962;156: 114-24.
26. Ogawa A, Sugo H, Takamori S, Kojima K, Fukasawa M, Beppu T, et al. Double cancers in the common bile duct: Molecular genetic findings with an analysis of LOH. J Hepatobiliary Pancreat Surg 2001;8:374-8.
27. Hanada K, Itoh M, Fujii K, Tsuchida A, Hirata M, Ishimaru S, et al. Pathology and cellular kinetics of gallbladder with an anomalous junction of the pancreaticobiliary duct. Am J Gastroenterol 1996; 91:1007-11.
28. Hanada K, Tsuchida A, Iwao T, Eguchi N, Sasaki T, Morinaka K, et al. Gene mutations of K-ras in gallbladder mucosae and gallbladder carcinoma with an anomalous junction of the pancreaticobiliary duct. Am J Gastroenterol 1999;94:1638-42.
29. Matsubara T, Funabiki T, Jinno O, Sakurai Y, Hasegawa S, Imazu H, et al. p53 gene mutations and overexpression of p53 product in cancerous and noncancerous biliary epithelium in patients with pancreaticobiliary maljunction. J Hepatobiliary Pancreat Surg 1999;6:286-93.